Elin R J, Hosseini J M, Gill J R
Clinical Pathology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892.
J Am Coll Nutr. 1994 Oct;13(5):463-6. doi: 10.1080/07315724.1994.10718435.
The purpose of this study was to determine the plasma, erythrocyte, and mononuclear blood cell (MBC) magnesium concentrations in patients with chronic, severe hypomagnesemia due to a chronic magnesium-wasting tubulopathy.
Six patients with Bartter's syndrome and five patients with magnesium-wasting tubulopathy were compared with normal subjects. We determined magnesium in plasma, erythrocytes, and MBCs.
Patients with chronic magnesium-wasting tubulopathy had a significantly lower plasma magnesium concentration than controls, but erythrocyte magnesium concentration and MBC magnesium concentration and content did not differ significantly between patients and controls.
Two disorders with chronic magnesium-wasting tubulopathies are associated with a low plasma magnesium concentration but normal erythrocyte and MBC magnesium.
本研究旨在测定因慢性镁消耗性肾小管病导致的慢性、重度低镁血症患者的血浆、红细胞及单核血细胞（MBC）镁浓度。
将6例巴特综合征患者和5例镁消耗性肾小管病患者与正常受试者进行比较。我们测定了血浆、红细胞及MBC中的镁含量。
慢性镁消耗性肾小管病患者的血浆镁浓度显著低于对照组，但患者与对照组之间的红细胞镁浓度、MBC镁浓度及含量无显著差异。
两种慢性镁消耗性肾小管病均与血浆镁浓度降低但红细胞和MBC镁正常有关。
